Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation

BACKGROUND/OBJECTIVE: In a previous report of HIV-infected patients with fat redistribution, we found that recombinant human growth hormone (rhGH) therapy reduced visceral adipose tissue (VAT) but increased insulin resistance, and that the addition of rosiglitazone reversed the negative effects of r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:HIV Clin Trials
Asıl Yazarlar: Leung, Vivien, Chiu, Ya-Lin, Kotler, Donald P., Albu, Jeanine, Zhu, Yuan-Shan, Ham, Kirsis, Engelson, Ellen S., Hammad, Hoda, Christos, Paul, Donovan, Daniel S., Ginsberg, Henry N., Glesby, Marshall J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941209/
https://ncbi.nlm.nih.gov/pubmed/27077672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15284336.2015.1126424
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller